Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2010
12/30/2010US20100331254 Pulverized fibrin clots and pharmaceutical compositions containing them
12/30/2010US20100331253 Method for cell adhesion and wound healing
12/30/2010US20100331251 Polypeptides homologous to vegf and bmp1
12/30/2010US20100331250 Anti-angiogenesis fusion proteins
12/30/2010US20100331246 Ester-based insulin prodrugs
12/30/2010US20100331245 Peptide yy analogs
12/30/2010US20100331244 Pharmaceutical composition, food or drink, and methods related thereto
12/30/2010US20100331241 Bacteriocins and Novel Bacterial Strains
12/30/2010US20100331239 Cd14 and peptides thereof for protection of cells against cell death
12/30/2010US20100331238 Human G protein-coupled receptor and modulators thereof for the treatment of atherosclerosis and atherosclerotic disease and for the treatment of conditions related to MCP-1 expression
12/30/2010US20100331237 Gag binding proteins
12/30/2010US20100331236 Cyclic peptides as g-protein coupled receptor antagonists
12/30/2010US20100331233 Crystal of xpa and ercc1 complex and uses thereof
12/30/2010US20100331206 Compositions and methods for early pregnancy diagnosis
12/30/2010US20100331193 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
12/30/2010US20100330701 Use of heat-resistant biotin-binding protein, and solid support having the protein attached thereto
12/30/2010US20100330668 Interaction Between the VHL Tumour Suppressor and Hypoxia Inducible Factor, and Assay Methods Relating Thereto
12/30/2010US20100330667 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level
12/30/2010US20100330657 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use
12/30/2010US20100330649 Expression systems for functional membrane polypeptides
12/30/2010US20100330618 Methods for producing biological substances in pigment-deficient mutants of bacillus cells
12/30/2010US20100330617 Methods of Producing a Secreted Protein
12/30/2010US20100330590 Assays using chimeric t1r3 taste receptor polypeptides
12/30/2010US20100330560 Immunogenic polypeptide isolated from mycobacterium avium subspecies paratuberculosis and uses thereof
12/30/2010US20100330554 Diagnostic kit for solid cancer and medicament for solid cancer therapy
12/30/2010US20100330249 Preparation of Soy Protein Isolate Using Calcium Chloride Extraction ("S703")
12/30/2010US20100330248 Production of Acid Soluble Soy Protein Isolates ("S700")
12/30/2010US20100330190 Immunogenic compositions and methods of use thereof
12/30/2010US20100330161 Oral delivery of tetanus toxoid
12/30/2010US20100330143 Modified macromolecules and methods of making and using thereof
12/30/2010US20100330124 Vaccine compositions and methods of use to protect against infectious disease
12/30/2010US20100330122 VARICELLA ZOSTER VIRUS VIRUS-LIKE PARTICLES (VLPs) AND ANTIGENS
12/30/2010US20100330121 Recombinant alphavirus-based vectors with reduced inhibition of cellular macro-molecular synthesis
12/30/2010US20100330115 Multivariable Antigens Complexed with Targeting Humanized Monoclonal Antibody
12/30/2010US20100330113 Vaccine Antigens
12/30/2010US20100330111 Increase of immune response and targeting by antigens and/or drug linkage
12/30/2010US20100330109 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
12/30/2010US20100330104 Methods of using btl-ii proteins
12/30/2010US20100330100 Pseudomonas aeruginosa-outer membrane protein pa4710
12/30/2010US20100330096 Methods of treating diseases with anti-vegf antibodies
12/30/2010US20100330088 Strategies to prevent and/or treat immunie responses to soluble allofactors
12/30/2010US20100330075 Monoclonal human tumor-specific antibody
12/30/2010US20100330074 Use of saccharides cross-reactive with bacillus anthracis spore glycoprotein as a vaccine against anthrax
12/30/2010US20100330073 Methods of treatment using antibodies to neutrokine-alpha
12/30/2010US20100330072 Myostatin binding agents
12/30/2010US20100330070 Methods Of Making An Antibody And Compositions Thereof
12/30/2010US20100330037 Adenoviral systems and the uses thereof
12/30/2010US20100330019 Keratin derivatives and methods of making the same
12/30/2010US20100329995 Compositions containing lactoferrin, and methods of using same to promote growth of skin cells
12/30/2010US20100329992 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3 expressing tumors
12/30/2010US20100329990 Luminescent markers
12/30/2010US20100329987 Uses of Sperm Membrane Protein OBF
12/30/2010US20100329983 Compounds and methods for the detection of trpv-6 cancers and drug delivery
12/30/2010US20100329977 Method for imaging tumor tissue
12/30/2010US20100329930 Streptavidin macromolecular adaptor and complexes thereof
12/29/2010WO2010151671A2 Treatment of tumor necrosis factor receptor 2 (tnfr2) related diseases by inhibition of natural antisense transcript to tnfr2
12/29/2010WO2010151609A1 Photoswitch-enabled ion channel assay system
12/29/2010WO2010151517A2 Antigen-specific long-term memory t-cells
12/29/2010WO2010151426A1 Truncated actriib-fc fusion proteins
12/29/2010WO2010151353A2 Injectable beta-hairpin peptide hydrogel that kills methicillin-resistant staphylococcus aureus
12/29/2010WO2010151159A2 Virus-like particle vector as a polyvalent platform for intracellular delivery of high-molecular-weight therapeutic substances, method for generating a virus like particle vector and use of a virus-like particle vector and a pharmaceutical composition containing said virus-like particle vector
12/29/2010WO2010150982A2 Recombinant hemagglutinin protein having superior biocompatibility for an influenza virus vaccine, and method for preparing biodegradable plga microspheres containing same
12/29/2010WO2010150862A1 Fluorescent temperature probe and temperature measuring device using same
12/29/2010WO2010150730A1 Process for production of peptide thioester
12/29/2010WO2010150650A1 Novel method for maintaining stem cells in an undifferentiated state
12/29/2010WO2010150525A1 Urate transporter, as well as method and kit for evaluating urate transport-related disease factor and inflammation-related disease factor, and test sample and drug
12/29/2010WO2010150375A1 Modified biotin-conjugated protein
12/29/2010WO2010150235A1 Multimeric polypeptides of hla-g including alpha1-alpha3 monomers and pharmaceutical uses thereof
12/29/2010WO2010150233A2 Multimeric polypeptides of hla-g including at least two alpha3 domains and pharmaceutical uses thereof
12/29/2010WO2010150230A1 Bacterial expression of an artificial gene for the production of crm197 and its derivatives
12/29/2010WO2010149964A2 Mutant proteins and methods for producing them
12/29/2010WO2010149960A1 Avian colony stimulating factor 1 receptor binding proteins
12/29/2010WO2010149792A2 Antimicrobial agents
12/29/2010WO2010149745A1 Recombinant rsv antigens
12/29/2010WO2010149721A1 A method for transforming a bacterium belonging to the streptococcus genus by natural competence
12/29/2010WO2010149657A1 Method for the purification of hbha
12/29/2010WO2010148511A1 Chimeric influenza virus-like particles comprising hemagglutinin
12/29/2010WO2010148501A1 Soricidin derived peptides and methods for the detection of trpv-6 cancers and drug delivery
12/29/2010WO2010148496A1 Lipidated tumor- associated antigens and immunotherapeutic compositions
12/29/2010WO2010148434A1 Chimeric molecules
12/29/2010WO2010148422A1 Compounds and methods for treating parasitic infestations
12/29/2010WO2010124843A3 Use of silintaphin for the structure-directed fabrication of (nano) composite materials in medicine and (nano) technology
12/29/2010WO2010106509A3 Hcv-derived polypeptides and uses thereof
12/29/2010WO2010068278A3 Production of carrier-peptide conjugates using chemically reactive unnatural amino acids
12/29/2010WO2009146463A8 Variant hhip1 protein and methods and uses thereof
12/29/2010WO2007122086A8 Transgenic plants and methods for controlling bolting in sugar beet
12/29/2010EP2267452A1 A soluble complex comprising a retroviral surface glycoprotein
12/29/2010EP2267448A1 Composition, kit and method for detecting neuropathy
12/29/2010EP2267447A1 Composition, kit and method for detecting aging and disease associated with vascular disorder
12/29/2010EP2267431A2 Gas sensor
12/29/2010EP2267158A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours
12/29/2010EP2267157A2 Identification of surface-associated antigenes used for the diagnosis and therapy of tumours
12/29/2010EP2267156A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours
12/29/2010EP2267153A1 Identification of netrin-1 receptor unc5c gene mutation in solid cancers
12/29/2010EP2267135A2 Protein glycosylation modification in pichia pastoris
12/29/2010EP2267132A2 Polyepitopic protein fragments of HPV proteins E6 and E7, method for obtaining same and uses thereof, in particular for vaccination
12/29/2010EP2267130A2 Bitter taste receptors
12/29/2010EP2267129A2 Bitter taste receptors
12/29/2010EP2267128A2 Bitter taste receptors
12/29/2010EP2267125A1 Cancer cell motility and cancer cell infiltration inhibitor
1 ... 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 ... 2916